共 180 条
[1]
Kola I(2004)Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 3 711-715
[2]
Landis J(2014)Clinical development success rates for investigational drugs Nat Biotechnol 32 40-51
[3]
Hay M(2018)Why drugs fail in late stages of development: case study analyses from the last decade and recommendations AAPS J 20 46-1164
[4]
Thomas DW(2017)Drug-induced liver injury: recent advances in diagnosis and risk assessment Gut. 66 1154-257
[5]
Craighead JL(2012)Drug-induced liver injury: present and future Clin Mol Hepatol 18 249-208
[6]
Economides C(2020)Drug-induced liver injury severity and toxicity (DILIst): binary classification of 1279 drugs by human hepatotoxicity Drug Discov Today 25 201-898
[7]
Rosenthal J(2016)Predicting drug-induced liver injury in human with Naïve Bayes classifier approach J Comput Aided Mol Des 30 889-107
[8]
Parasrampuria DA(2017)Development of decision Forest models for prediction of drug-induced liver injury in humans using a large set of FDA-approved drugs Sci Rep 7 17311-653
[9]
Benet LZ(2018)Predicting drug-induced liver injury using ensemble learning methods and molecular fingerprints Toxicol Sci 165 100-1452.e17
[10]
Sharma A(2019)Deep neural network models for predicting chemically induced liver toxicity endpoints from Transcriptomic responses Front Pharmacol 10 42-5